Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1](S0165032716304499)(10.1016/j.jad.2016.08.029)

D. Mischoulon, L. Hylek, A. S. Yeung, A. J. Clain, L. Baer, C. Cusin, D. F. Ionescu, Jonathan E. Alpert, D. P. Soskin, M. Fava

Research output: Contribution to journalComment/debate

Abstract

The authors regret that the order of the authors was incorrect. The correct order is the following: Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Fava M, Soskin DP. As mentioned in the original publication, Drs Soskin and Fava contributed equally to the inception, hypotheses, and design that formed the basis of the study and are considered as co-senior authors. The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Number of pages1
JournalJournal of Affective Disorders
Volume227
DOIs
StatePublished - Feb 1 2017
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this